Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro Diagnostics

PUBLISHER: Transparency Market Research | PRODUCT CODE: 1592719

Cover Image

PUBLISHER: Transparency Market Research | PRODUCT CODE: 1592719

In-vitro Inflammatory Bowel Disease Diagnostics Market (Testing Type: Laboratory-based Testing, Point-of-Care Testing, and Self-testing Kits) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

PUBLISHED:
PAGES: 176 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5795
PDF (Multi-user License)
USD 8795
PDF (Corporate License)
USD 11795

Add to Cart

Description

Table of Contents

List of Tables

In-vitro Inflammatory Bowel Disease Diagnostics Market - Scope of Report

TMR's report on the global in-vitro inflammatory bowel disease diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global in-vitro inflammatory bowel disease diagnostics market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global in-vitro inflammatory bowel disease diagnostics market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the in-vitro inflammatory bowel disease diagnostics market.

Market Snapshot
Market Value in 2023US$ 1.6 Bn
Market Value in 2034US$ 2.9 Bn
CAGR5.6%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global in-vitro inflammatory bowel disease diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global in-vitro inflammatory bowel disease diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global in-vitro inflammatory bowel disease diagnostics market.

The report delves into the competitive landscape of the global in-vitro inflammatory bowel disease diagnostics market. Key players operating in the global in-vitro inflammatory bowel disease diagnostics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global in-vitro inflammatory bowel disease diagnostics market profiled in this report.

Key Questions Answered in Global in-vitro inflammatory bowel disease diagnostics Market Report:

  • What is the sales/revenue generated by in-vitro inflammatory bowel disease diagnostics across all regions during the forecast period?
  • What are the opportunities in the global in-vitro inflammatory bowel disease diagnostics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

In-vitro Inflammatory Bowel Disease Diagnostics Market - Research Objectives and Research Approach

The comprehensive report on the global in-vitro inflammatory bowel disease diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global in-vitro inflammatory bowel disease diagnostics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global in-vitro inflammatory bowel disease diagnostics market.

Show more
Product Code: TMRGL74162

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global In-Vitro Inflammatory Bowel Disease Diagnostics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecasts, 2020 - 2034

5. Key Insights

  • 5.1. Key Product/Brand Analysis
  • 5.2. Technological Outlook
  • 5.3. Disease Prevalence and Incidence Rate of Colorectal Cancer in Europe
  • 5.4. Overview: National Screening Program Scenario
  • 5.5. Regulatory Scenario in Europe

6. Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecasts, By Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Product, 2020 - 2034
    • 6.3.1. Assays/Biomarker
      • 6.3.1.1. Calprotectin
      • 6.3.1.2. Lactoferrin
      • 6.3.1.3. Bile Acids
      • 6.3.1.4. H. pylori SA
      • 6.3.1.5. Pancreatic Elastase
      • 6.3.1.6. Others
    • 6.3.2. Analyzers
  • 6.4. Market Attractiveness By Product

7. Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecasts, By Testing Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Testing Type, 2020 - 2034
    • 7.3.1. Laboratory-based Testing
    • 7.3.2. Point-of-Care (POC) Testing
    • 7.3.3. Self-testing Kits
  • 7.4. Market Attractiveness By Testing Type

8. Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecasts, By End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By End-user, 2020 - 2034
    • 8.3.1. Diagnostic Laboratories
    • 8.3.2. Hospitals
    • 8.3.3. Others (Homecare Testing & Research Institutes etc.)
  • 8.4. Market Attractiveness By End-user

9. Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecasts, By Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast By Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness By Country/Region

10. North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Product, 2020 - 2034
    • 10.2.1. Assays/Biomarker
      • 10.2.1.1. Calprotectin
      • 10.2.1.2. Lactoferrin
      • 10.2.1.3. Bile Acids
      • 10.2.1.4. H. pylori SA
      • 10.2.1.5. Pancreatic Elastase
      • 10.2.1.6. Others
    • 10.2.2. Analyzers
  • 10.3. Market Value Forecast By Testing Type, 2020 - 2034
    • 10.3.1. Laboratory-based Testing
    • 10.3.2. Point-of-Care (POC) Testing
    • 10.3.3. Self-testing Kits
  • 10.4. Market Value Forecast By End-user, 2020 - 2034
    • 10.4.1. Diagnostic Laboratories
    • 10.4.2. Hospitals
    • 10.4.3. Others (Homecare Testing & Research Institutes etc.)
  • 10.5. Market Value Forecast By Country, 2020 - 2034
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product
    • 10.6.2. By Testing Type
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Product, 2020 - 2034
    • 11.2.1. Assays/Biomarker
      • 11.2.1.1. Calprotectin
      • 11.2.1.2. Lactoferrin
      • 11.2.1.3. Bile Acids
      • 11.2.1.4. H. pylori SA
      • 11.2.1.5. Pancreatic Elastase
      • 11.2.1.6. Others
    • 11.2.2. Analyzers
  • 11.3. Market Value Forecast By Testing Type, 2020 - 2034
    • 11.3.1. Laboratory-based Testing
    • 11.3.2. Point-of-Care (POC) Testing
    • 11.3.3. Self-testing Kits
  • 11.4. Market Value Forecast By End-user, 2020 - 2034
    • 11.4.1. Diagnostic Laboratories
    • 11.4.2. Hospitals
    • 11.4.3. Others (Homecare Testing & Research Institutes etc.)
  • 11.5. Market Value Forecast By Country, 2020 - 2034
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Product
    • 11.6.2. By Testing Type
    • 11.6.3. By End-user
    • 11.6.4. By Country

12. Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Product, 2020 - 2034
    • 12.2.1. Assays/Biomarker
      • 12.2.1.1. Calprotectin
      • 12.2.1.2. Lactoferrin
      • 12.2.1.3. Bile Acids
      • 12.2.1.4. H. pylori SA
      • 12.2.1.5. Pancreatic Elastase
      • 12.2.1.6. Others
    • 12.2.2. Analyzers
  • 12.3. Market Value Forecast By Testing Type, 2020 - 2034
    • 12.3.1. Laboratory-based Testing
    • 12.3.2. Point-of-Care (POC) Testing
    • 12.3.3. Self-testing Kits
  • 12.4. Market Value Forecast By End-user, 2020 - 2034
    • 12.4.1. Diagnostic Laboratories
    • 12.4.2. Hospitals
    • 12.4.3. Others (Homecare Testing & Research Institutes etc.)
  • 12.5. Market Value Forecast By Country, 2020 - 2034
    • 12.5.1. China
    • 12.5.2. India
    • 12.5.3. Japan
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product
    • 12.6.2. By Testing Type
    • 12.6.3. By End-user
    • 12.6.4. By Country

13. Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Product, 2020 - 2034
    • 13.2.1. Assays/Biomarker
      • 13.2.1.1. Calprotectin
      • 13.2.1.2. Lactoferrin
      • 13.2.1.3. Bile Acids
      • 13.2.1.4. H. pylori SA
      • 13.2.1.5. Pancreatic Elastase
      • 13.2.1.6. Others
    • 13.2.2. Analyzers
  • 13.3. Market Value Forecast By Testing Type, 2020 - 2034
    • 13.3.1. Laboratory-based Testing
    • 13.3.2. Point-of-Care (POC) Testing
    • 13.3.3. Self-testing Kits
  • 13.4. Market Value Forecast By End-user, 2020 - 2034
    • 13.4.1. Diagnostic Laboratories
    • 13.4.2. Hospitals
    • 13.4.3. Others (Homecare Testing & Research Institutes etc.)
  • 13.5. Market Value Forecast By Country, 2020 - 2034
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Product
    • 13.6.2. By Testing Type
    • 13.6.3. By End-user
    • 13.6.4. By Country

14. Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Product, 2020 - 2034
    • 14.2.1. Assays/Biomarker
      • 14.2.1.1. Calprotectin
      • 14.2.1.2. Lactoferrin
      • 14.2.1.3. Bile Acids
      • 14.2.1.4. H. pylori SA
      • 14.2.1.5. Pancreatic Elastase
      • 14.2.1.6. Others
    • 14.2.2. Analyzers
  • 14.3. Market Value Forecast By Testing Type, 2020 - 2034
    • 14.3.1. Laboratory-based Testing
    • 14.3.2. Point-of-Care (POC) Testing
    • 14.3.3. Self-testing Kits
  • 14.4. Market Value Forecast By End-user, 2020 - 2034
    • 14.4.1. Diagnostic Laboratories
    • 14.4.2. Hospitals
    • 14.4.3. Others (Homecare Testing & Research Institutes etc.)
  • 14.5. Market Value Forecast By Country, 2020 - 2034
    • 14.5.1. GCC
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Product
    • 14.6.2. By Testing Type
    • 14.6.3. By End-user
    • 14.6.4. By Country

15. Competition Landscape

  • 15.1. Global Dental Bearings Market : Company Share Analysis (2023)
  • 15.2. Company Profiles
    • 15.2.1. F. Hoffmann-La Roche AG
      • 15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.1.2. Product Portfolio
      • 15.2.1.3. Financial Overview
      • 15.2.1.4. SWOT Analysis
      • 15.2.1.5. Strategic Overview
    • 15.2.2. Thermo Fisher Scientific Inc.
      • 15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.2.2. Product Portfolio
      • 15.2.2.3. Financial Overview
      • 15.2.2.4. SWOT Analysis
      • 15.2.2.5. Strategic Overview
    • 15.2.3. Abbott Laboratories
      • 15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.3.2. Product Portfolio
      • 15.2.3.3. Financial Overview
      • 15.2.3.4. SWOT Analysis
      • 15.2.3.5. Strategic Overview
    • 15.2.4. Sentinel Diagnostic
      • 15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.4.2. Product Portfolio
      • 15.2.4.3. Financial Overview
      • 15.2.4.4. SWOT Analysis
      • 15.2.4.5. Strategic Overview
    • 15.2.5. BTNX Inc.
      • 15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.5.2. Product Portfolio
      • 15.2.5.3. Financial Overview
      • 15.2.5.4. SWOT Analysis
      • 15.2.5.5. Strategic Overview
    • 15.2.6. Immundiagnostik AG
      • 15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.6.2. Product Portfolio
      • 15.2.6.3. Financial Overview
      • 15.2.6.4. SWOT Analysis
      • 15.2.6.5. Strategic Overview
    • 15.2.7. Quest Diagnostics
      • 15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.7.2. Product Portfolio
      • 15.2.7.3. Financial Overview
      • 15.2.7.4. SWOT Analysis
      • 15.2.7.5. Strategic Overview
    • 15.2.8. Sysmex Europe SE
      • 15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.8.2. Product Portfolio
      • 15.2.8.3. Financial Overview
      • 15.2.8.4. SWOT Analysis
      • 15.2.8.5. Strategic Overview
    • 15.2.9. Diasorin S.p.A
      • 15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.9.2. Product Portfolio
      • 15.2.9.3. Financial Overview
      • 15.2.9.4. SWOT Analysis
      • 15.2.9.5. Strategic Overview
    • 15.2.10. BioSystems S.A.
      • 15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.10.2. Product Portfolio
      • 15.2.10.3. Financial Overview
      • 15.2.10.4. SWOT Analysis
      • 15.2.10.5. Strategic Overview
    • 15.2.11. QuidelOrtho Corporation
      • 15.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.11.2. Product Portfolio
      • 15.2.11.3. Financial Overview
      • 15.2.11.4. SWOT Analysis
      • 15.2.11.5. Strategic Overview
    • 15.2.12. Other Prominent Players
      • 15.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.12.2. Product Portfolio
      • 15.2.12.3. Financial Overview
      • 15.2.12.4. SWOT Analysis
      • 15.2.12.5. Strategic Overview
Show more
Product Code: TMRGL74162

In-vitro Inflammatory Bowel Disease Diagnostics Market

In-vitro Inflammatory Bowel Disease Diagnostics Industry

In-vitro Inflammatory Bowel Disease Diagnostics Market Size

In-vitro Inflammatory Bowel Disease Diagnostics Market Share

In-vitro Inflammatory Bowel Disease Diagnostics Market Growth

In-vitro Inflammatory Bowel Disease Diagnostics Market Analysis

In-vitro Inflammatory Bowel Disease Diagnostics Market Demand

In-vitro Inflammatory Bowel Disease Diagnostics Market Forecast

In-vitro Inflammatory Bowel Disease Diagnostics Market Trends

List of Tables

  • Table 01: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Product, 2020-2034
  • Table 02: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Assays/Biomarker, 2020-2034
  • Table 03: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Testing Type, 2020-2034
  • Table 04: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 05: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Region, 2020-2034
  • Table 06: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Country, 2020-2034
  • Table 07: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Product, 2020-2034
  • Table 08: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Product, 2020-2034
  • Table 09: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Testing Type, 2020-2034
  • Table 10: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 11: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 12: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Product, 2020-2034
  • Table 13: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Product, 2020-2034
  • Table 14: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Testing Type, 2020-2034
  • Table 15: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 16: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 17: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Product, 2020-2034
  • Table 18: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Product, 2020-2034
  • Table 19: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Testing Type, 2020-2034
  • Table 20: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 21: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Product, 2020-2034
  • Table 23: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Product, 2020-2034
  • Table 24: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Testing Type, 2020-2034
  • Table 25: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 26: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 27: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Product, 2020-2034
  • Table 28: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Product, 2020-2034
  • Table 29: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Testing Type, 2020-2034
  • Table 30: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2020-2034

List of Figures

  • Figure 01: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, 2020-2034
  • Figure 02: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share, by Product, 2023
  • Figure 03: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share, by Testing Type, 2023
  • Figure 04: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share, by End-user, 2023
  • Figure 05: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by Product, 2023 and 2034
  • Figure 06: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Share Analysis, by Product, 2023
  • Figure 07: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Share Analysis, by Product, 2034
  • Figure 08: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Product, 2024-2034
  • Figure 09: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn), by Assays/Biomarker, 2020-2034
  • Figure 10: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Assays/Biomarker, 2024 and 2034
  • Figure 11: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn), by Analyzers, 2020-2034
  • Figure 12: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Analyzers, 2024 and 2034
  • Figure 13: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by Testing Type, 2023 and 2034
  • Figure 14: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Share Analysis, by Testing Type, 2023
  • Figure 15: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Share Analysis, by Testing Type, 2034
  • Figure 16: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Testing Type, 2024-2034
  • Figure 17: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn), by Clinical Testing Type, 2020-2034
  • Figure 18: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Laboratory-based Testing, 2024 and 2034
  • Figure 19: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn), by Point-of-Care (POC) Testing, 2020-2034
  • Figure 20: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Point-of-Care (POC) Testing, 2024 and 2034
  • Figure 21: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn), by Self-testing Kits, 2020-2034
  • Figure 22: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Self-testing Kits, 2024 and 2034
  • Figure 23: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034
  • Figure 24: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Share Analysis, by End-user, 2023
  • Figure 25: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Share Analysis, by End-user, 2034
  • Figure 26: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 27: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn), by Hospitals, 2020-2034
  • Figure 28: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Hospitals, 2024 and 2034
  • Figure 29: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn), by Diagnostic Laboratories, 2020-2034
  • Figure 30: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Diagnostic Laboratories, 2024 and 2034
  • Figure 31: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn), by Others, 2020-2034
  • Figure 32: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Others, 2024 and 2034
  • Figure 33: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 34: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Share Analysis, by Region, 2023
  • Figure 35: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Share Analysis, by Region, 2034
  • Figure 36: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 37: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 38: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 39: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 40: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by Product, 2023 and 2034
  • Figure 41: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Product, 2024-2034
  • Figure 42: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by Testing Type, 2023 and 2034
  • Figure 43: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Testing Type, 2024-2034
  • Figure 44: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034
  • Figure 45: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 46: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 47: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 48: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 49: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by Product, 2023 and 2034
  • Figure 50: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Product, 2024-2034
  • Figure 51: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by Testing Type, 2023 and 2034
  • Figure 52: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Testing Type, 2024-2034
  • Figure 53: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034
  • Figure 54: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 55: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 56: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 57: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 58: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by Product, 2023 and 2034
  • Figure 59: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Product, 2024-2034
  • Figure 60: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by Testing Type, 2023 and 2034
  • Figure 61: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Testing Type, 2024-2034
  • Figure 62: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034
  • Figure 63: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 64: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 65: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 66: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 67: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by Product, 2023 and 2034
  • Figure 68: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Product, 2024-2034
  • Figure 69: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by Testing Type, 2023 and 2034
  • Figure 70: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Testing Type, 2024-2034
  • Figure 71: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034
  • Figure 72: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 73: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 74: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 75: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 76: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by Product, 2023 and 2034
  • Figure 77: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Product, 2024-2034
  • Figure 78: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by Testing Type, 2023 and 2034
  • Figure 79: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Testing Type, 2024-2034
  • Figure 80: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034
  • Figure 81: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!